Intellia Therapeutics stock opened at $26.10 on Friday. The stock’s 50-day moving average is $27.92 and its 200-day moving average is $30.40. The company has a market cap of $2.34 billion, a ...In 4 weeks Intellia Therapeutics stock prediction on Friday, March, 22: 27.95 dollars, maximum 30.19, minimum 25.71. Intellia Therapeutics stock price forecast ...View a financial market summary for NTLA including stock price quote, trading volume, volatility, options volume, statistics, and other important company data related to NTLA (Intellia Therapeutics) stock. ... What is Intellia Therapeutics stock price doing today? As of February 23, 2024, NTLA stock price declined to $26.10 with …View today's Intellia Therapeutics Inc stock price and latest NTLA news and analysis. Create real-time notifications to follow any changes in the live stock price.Mar 3, 2022 · Intellia Therapeutics. Market Cap. $2B. Today's Change. (-2.13%) -$0.59. Current Price. $27.15. Price as of February 20, 2024, 4:00 p.m. ET. You’re reading a free article with opinions that may ... A company's cash runway is calculated by dividing its cash hoard by its cash burn. In September 2023, Intellia Therapeutics had US$855m in cash, and was debt-free. In the last year, its cash burn ...On Friday, Canaccord Genuity maintained a Buy rating on Intellia Therapeutics (NASDAQ: NTLA ) and slightly increased the price target to $73 from $72.The adjustment follows Intellia's fourth-quarter earnings report, which aligned with expectations set by an early January pre-announcement.Intellia Therapeutics Stock Earnings. The value each NTLA share was expected to gain vs. the value that each NTLA share actually gained. Intellia Therapeutics ( NTLA) reported Q3 2023 earnings per share (EPS) of -$1.38, beating estimates of -$1.50 by 7.99%. In the same quarter last year, Intellia Therapeutics 's earnings per share (EPS) was -$1.49.Wall Street analysts are quite bullish about Intellia Therapeutics (NTLA-2.84%) stock. On average, they're estimating that it'll rise by around 157% within the next 12 months. In the context of ...Research Intellia Therapeutics' (Nasdaq:NTLA) stock key valuation metrics while comparing it with its industry peers & market side by side. ... The above table shows the analyst NTLA forecast and predictions for the stock price in 12 month’s time. Date Share Price Average 1Y Price Target Dispersion High Low 1Y Actual price Analysts; Current ...As of the second quarter of 2023, Intellia has nearly $1 billion in cash, equivalents, and short-term investments. Its trailing-12-month operating expenses are $513 million. Therefore, to continue ...Intellia Therapeutics, Inc. Common Stock (NTLA) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US and global markets. About the Intellia Therapeutics, Inc. stock forecast. As of 2024 February 18, Sunday current price of NTLA stock is 27.720$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).. Intellia Therapeutics stock price has been showing a declining tendency so we believe that similar market …4 days ago · Intellia Therapeutics stock gains on CRISPR treatment results. Intellia Therapeutics Inc. NTLA, -0.28% shares gained 6.4% premarket on Monday after the clinical stage genome-editing company announced new data from a trial of an investigational CRISPR-based therap... Other symbols: CRSP. Feb 16, 2024 · NTLA, Intellia Therapeutics - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines Dec 3, 2021 · Intellia Therapeutics, Inc. Common Stock (NTLA) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.18 Mar 2021 ... The stock price of Intellia Therapeutics, a biotechnology company developing treatments using a CRISPR gene-editing system, has seen a solid ...Jan 4, 2024 · Intellia Contacts: Investors: Ian Karp Senior Vice President, Investor Relations and Corporate Communications ... and got the Nvidia logo tattooed on his shoulder when the stock price hit $100. In 4 weeks Intellia Therapeutics stock prediction on Friday, March, 22: 27.95 dollars, maximum 30.19, minimum 25.71. Intellia Therapeutics stock price forecast ...Analyst's Opinion · Consensus Rating. Intellia Therapeutics has received a consensus rating of Moderate Buy. · Price Target Upside/Downside. According to ...NTLA Stock 12 Months Forecast. Based on 17 Wall Street analysts offering 12 month price targets for Intellia Therapeutics in the last 3 months. The average price target is $79.21 with a high forecast of $136.00 and a low forecast of $31.00. The average price target represents a 186.27% change from the last price of $27.67. 4 days ago · Intellia Therapeutics, Inc. (NASDAQ:NTLA) is a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies. The …Feb 8, 2024 · The 17 analysts with 12-month price forecasts for NTLA stock have an average target of 76.76, with a low estimate of 40 and a high estimate of 136. The average target predicts an increase of 179.43% from the current stock price of 27.47. Intellia Therapeutics Stock Earnings. The value each NTLA share was expected to gain vs. the value that each NTLA share actually gained. Intellia Therapeutics ( NTLA) reported Q3 2023 earnings per share (EPS) of -$1.38, beating estimates of -$1.50 by 7.99%. In the same quarter last year, Intellia Therapeutics 's earnings per share (EPS) was -$1.49.View live Intellia Therapeutics, Inc. chart to track its stock's price action. Find market predictions, NTLA financials and market news.4 days ago · Intellia Therapeutics stock gains on CRISPR treatment results. Intellia Therapeutics Inc. NTLA, -0.28% shares gained 6.4% premarket on Monday after the clinical stage genome-editing company announced new data from a trial of an investigational CRISPR-based therap... Other symbols: CRSP. Intellia Therapeutics Announces Publication of Positive Interim Phase 1 Data for NTLA-2002 in Patients with Hereditary Angioedema in the New England Journal of Medicine. Find the latest Intellia Therapeutics, Inc. (NTLA) stock quote, history, news and other vital information to help you with your stock trading and investing.Intellia Therapeutics stock prediction for May 2025. The forecast for beginning 52.37 dollars. Maximum price 58.68, minimum 49.98. Averaged Intellia Therapeutics stock price for the month 53.84. At the end 54.33 dollars, change for May 3.7%. Intellia Therapeutics stock price forecast for June 2025.Get the latest Intellia Therapeutics, Inc. (NTLA) stock news and headlines to help you in your trading and investing decisions. Wall Street Stock Market & Finance report, prediction for the future: You'll find the Intellia Therapeutics share forecasts, stock quote and buy / sell signals below. According to present data Intellia Therapeutics's NTLA shares and potentially its market environment have been in bearish cycle last 12 months (if exists).3 days ago · NTLA | Complete Intellia Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.5 days ago · The Intellia Therapeutics Inc stock price fell by -0.99% on the last day (Wednesday, 21st Feb 2024) from $27.15 to $26.88. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 3.88% from a day low at $26.26 to a day high of $27.28. The price has been going up and down for this period, and there has been a 1.17% ... Fiscal Q3 2023 ended 9/30/23. Reported on 11/9/23. Get the latest Intellia Therapeutics Inc (NTLA) real-time quote, historical performance, charts, and other financial information to help you... Nasdaq provides Price/Earnings Ratio (or PE Ratio) and PEG ratio for stock evaluation. Financial analysts and individual investors use PE Ratio and PEG ratios to determine the financial ...Nov 10, 2023 · General and administrative expenses surged 32.8% year over year to $29.4 million due to an increase in stock-based compensation of $5.3 million. ... Intellia Therapeutics, Inc. Price and Consensus. Get Intellia Therapeutics Inc (NTLA.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments.Open a brokerage account and deposit funds in it to purchase stock in a company, explains the Wall Street Journal. Companies such as Charles Schwab, E-Trade, and Ameritrade provide...Based on 33 Wall street analysts offering stock ratings for Intellia Therapeutics Inc.(by analysts ranked 0 to 5 stars) Based on 33 analyst. Current; 1M Ago; 3M Ago; Buy. 28. 28. 29. Hold. 5. 5. 5. Sell. 0 0. 0 0. 0 0. Analyst Forecast. ... Intellia Therapeutics Inc.’s price-to-earnings ratio stands at None.This price target is based on 19 analysts offering 12 month price targets for Intellia Therapeutics in the last 3 months. The average price target is $74.11, with a high forecast of $136.00 and a low forecast of $29.00. The average price target represents a 174.08% upside from the last price of $27.04.Get the latest Intellia Therapeutics Inc. (NTLA) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals. On Friday, Canaccord Genuity maintained a Buy rating on Intellia Therapeutics (NASDAQ: NTLA) and slightly increased the price target to $73 from $72.The adjustment follows Intellia's fourth-quarter earnings report, which aligned with expectations set by an early January pre-announcement.Feb 17, 2024 · The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Intellia Therapeutics wasn’t one of them. The 10 stocks that ... Intellia Therapeutics (NTLA Quick Quote NTLA - Free Report) reported third-quarter 2023 loss of $1.38 per share, narrower than the Zacks Consensus Estimate of a loss of $1.52. In the year-ago ...Intellia Therapeutics Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Intellia Therapeutics Inc is Bearish, which is based on 2 positive signals and 6 negative signals. At the last closing, Intellia Therapeutics Inc’s …5 days ago · The Intellia Therapeutics Inc stock price fell by -0.99% on the last day (Wednesday, 21st Feb 2024) from $27.15 to $26.88. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 3.88% from a day low at $26.26 to a day high of $27.28. The price has been going up and down for this period, and there has been a 1.17% ... The consensus price target hints at an 185.5% upside potential for Intellia Therapeutics, Inc. (NTLA). While empirical research shows that this sought-after metric is hardly effective, an upward ...Real stock prices are not the same as the last traded stock price. Real stock prices are adjustments to closing stock prices. The adjustments are used in a variety of ways, includi...This price target is based on 19 analysts offering 12 month price targets for Intellia Therapeutics in the last 3 months. The average price target is $74.11, with a high forecast of $136.00 and a low forecast of $29.00. The average price target represents a 174.08% upside from the last price of $27.04.Intellia Therapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. NTLA updated stock price target summary. CRISPR specialist Intellia Therapeutics on Thursday said it will lay off about 15% of its workforce as it pauses some early-stage research.. The cuts come a little over three months after Intellia, one of the first companies founded to turn the gene editing technology into medicines, received a green light from U.S. regulators to begin a late …5 May 2016 ... Intellia's common stock is expected to begin trading on the NASDAQ Global Market under the ticker symbol "NTLA" on May 6, 2016 . Credit Suisse , ....These 4 analysts have an average price target of $80.75 versus the current price of Intellia Therapeutics at $23.64, implying upside. Below is a summary of how these 4 analysts rated Intellia ...NTLA - Intellia Therapeutics, Inc. Stock - Share Price, Short Interest, Short Squeeze, Borrow Rates (NasdaqGM)Analyst Salveen Richter from Goldman Sachs downgraded the rating on the stock to a Hold and gave it a $32.00 price target. Intellia Therapeutics (NTLA) is a company developing gene editing-based therapies. The timeline for significant events in the company's pipeline stretches into 2024 and beyond.3 days ago · View Intellia Therapeutics, Inc NTLA investment & stock information. Get the latest Intellia Therapeutics, Inc NTLA detailed stock quotes, stock data, Real-Time ECN, …Find the latest Intellia Therapeutics, Inc. (NTLA) stock quote, history, news and other vital information to help you with your stock trading and investing. Find the latest Intellia Therapeutics, Inc. (NTLA) stock quote, history, news and other vital information to help you with your stock trading and investing. Intellia Therapeutics, Inc. (NTLA) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term. Zacks.Earnings Date. Feb 22, 2024. Forward Dividend & Yield. N/A (N/A) Ex-Dividend Date. N/A. 1y Target Est. 75.13. Fair Value is the appropriate price for the shares of a company, based on its... Intellia Therapeutics stock rose 15% over a five-day trading period ending 3/16/2021, compared to a broader market (S&P500) rise of 2.6%. A change of 15% or more over five trading days is a 9% ...Intellia Therapeutics Inc’s Stock Price Change Based on Its Q3 Earnings Report. The stock market is considered to always be “forward-looking,” which means share prices are established based on the expectations that prospective investors have for the future earnings power of the company. In fact, expectations play a key role in determining ...The latest price target for . Intellia Therapeutics (NASDAQ: NTLA) was reported by Oppenheimer on November 13, 2023.The analyst firm set a price target for $70.00 expecting NTLA to rise to within ...Intellia Thera CS stocks price quote with latest real-time prices, charts, financials, latest news, ... Better Growth Stock: Intellia Therapeutics vs. CRISPR Therapeutics Motley Fool - Sun Jan 21, 7:00AM CST . Both companies are going to …The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Intellia Therapeutics wasn't one of them.RBC Cuts Price Target on Intellia Therapeutics to $70 From $80, Keeps Outperform, Speculative Risk Nov. 10: MT Wedbush Lowers Intellia Therapeutics' Price Target to $29 From $45, Maintains Neutral Rating Nov. 10: MT Intellia Therapeutics Shares Fall After Net Loss Narrows, but Revenue Falls in Q3 ... Stock Intellia Therapeutics, Inc. …On Friday, Canaccord Genuity maintained a Buy rating on Intellia Therapeutics (NASDAQ: NTLA) and slightly increased the price target to $73 from $72.The adjustment follows Intellia's fourth-quarter earnings report, which aligned with expectations set by an early January pre-announcement.Of note is the ratio of INTELLIA THERAPEUTICS INC's sales and general administrative expense to its total operating expenses; only 7.7% of US stocks have a lower such ratio. NTLA's price/sales ratio is 51.02; that's higher than the P/S ratio of 96.61% of US stocks.Complete Intellia Therapeutics Inc. stock information by Barron's. View real-time NTLA stock price and news, along with industry-best analysis. Intellia Therapeutics. Market Cap. $2B. Today's Change. (-0.99%) -$0.27. Current Price. $26.88. Price as of February 21, 2024, 4:00 p.m. ET. You’re reading a free article with opinions that may ...Since its IPO on the Shenzhen stock exchange, its share price has gone up every day by the exact same amount. Baofeng Technologies is China’s best performing stock this year. Since...Real stock prices are not the same as the last traded stock price. Real stock prices are adjustments to closing stock prices. The adjustments are used in a variety of ways, includi...1 Dec 2022 ... ... pricing of an underwritten public offering of 6,550,219 shares of its common stock at a public offering price of US$45.80 per share. Intellia ...On Friday, Canaccord Genuity maintained a Buy rating on Intellia Therapeutics (NASDAQ: NTLA) and slightly increased the price target to $73 from $72.The adjustment follows Intellia's fourth-quarter earnings report, which aligned with expectations set by an early January pre-announcement.If you need cash, aren’t happy with your investment returns or want to diversify your investments, you may have to liquidate some of your stocks. Buying and selling stocks is extre...According to Accountingbase.com, common stock is neither an asset nor a liability; it is considered equity. Equity is basically considered to mathematically be the difference betwe...Intellia Therapeutics, Inc. (NTLA) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term. Zacks.On Friday, Canaccord Genuity maintained a Buy rating on Intellia Therapeutics (NASDAQ: NTLA) and slightly increased the price target to $73 from $72.The adjustment follows Intellia's fourth-quarter earnings report, which aligned with expectations set by an early January pre-announcement.If you need cash, aren’t happy with your investment returns or want to diversify your investments, you may have to liquidate some of your stocks. Buying and selling stocks is extre...MT. Wedbush Lowers Intellia Therapeutics' Price Target to $29 From $45, Maintains Neutral Rating. Nov. 10. MT. Intellia Therapeutics Shares Fall After Net Loss Narrows, but Revenue Falls in Q3. Nov. 09. MT. Transcript : Intellia Therapeutics, Inc., Q3 2023 Earnings Call, Nov 09, 2023.NasdaqGM - NasdaqGM Real Time Price. Currency in USD. Follow. Visitors trend 2W 10W 9M. 27.15-0.59 (-2.13%) At close: 04:00PM EST. ... Intellia Therapeutics, Inc., a genome editing company ...Intellia Therapeutics, Inc. Common Stock (NTLA) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading activity data for US and global markets. Intellia Therapeutics Stock Earnings. The value each NTLA share was expected to gain vs. the value that each NTLA share actually gained. Intellia Therapeutics ( NTLA) reported Q3 2023 earnings per share (EPS) of -$1.38, beating estimates of -$1.50 by 7.99%. In the same quarter last year, Intellia Therapeutics 's earnings per share (EPS) was -$1.49.3 days ago · On Friday, Canaccord Genuity maintained a Buy rating on Intellia Therapeutics (NASDAQ:) and slightly increased the price target to $73 from $72. The adjustment follows Intellia’s fourth-quarter earnings report, which aligned with expectations set by an early January pre-announcement. Today's Open. $27.00. Previous Close. $27.15. Today's High. $27.30. Today's Low. $26.26. The Investor Relations website contains information about Intellia Therapeutics's business for stockholders, potential investors, and financial analysts.Get the latest Intellia Therapeutics Inc (38I) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Penny stocks may sound like an interesting investment option, but there are some things that you should consider before deciding whether this is the right investment choice for you...On Friday, Canaccord Genuity maintained a Buy rating on Intellia Therapeutics (NASDAQ: NTLA ) and slightly increased the price target to $73 from $72.The adjustment follows Intellia's fourth-quarter earnings report, which aligned with expectations set by an early January pre-announcement.While it's true that there are a few positive catalysts coming for Intellia's stock, it's difficult to see how the share price could possibly rise by as much as Wall Street currently calculates ...Are you tired of spending endless hours searching for high-quality stock photos only to discover that they come with a hefty price tag? Look no further. In this article, we will ex...
Intellia Therapeutics Stock Forecast. ... The 17 analysts with 12-month price forecasts for NTLA stock have an average target of 76.76, with a low estimate of 40 and a high estimate of 136. The average target predicts an increase of 176.71% from the current stock price of 27.74.. Lesbin sexy video
Dec 5, 2023 · Intellia Therapeutics, Inc. (0JBU.LON) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Intellia Therapeutics, Inc. | London Stock ... Intellia Thera CS (NTLA) $27.15 0.59 (2.13%) 16:00 EST NTLA Stock Quote Delayed 30 Minutes.According to Accountingbase.com, common stock is neither an asset nor a liability; it is considered equity. Equity is basically considered to mathematically be the difference betwe...When it comes to purchasing a new vehicle, finding the perfect car that meets all your requirements can be a daunting task. If you have your heart set on a Genesis GV70, you’ll wan...Complete Intellia Therapeutics Inc. stock information by Barron's. View real-time NTLA stock price and news, along with industry-best analysis.Yet despite these upgrades, the analysts cut their price target 8.0% to US$76.36, implicitly signalling that the ongoing losses are likely to weigh negatively on Intellia Therapeutics' valuation.29 Dec 2023 ... About Intellia Therapeutics Inc (NTLA). Before we jump into Intellia Therapeutics Inc's stock price, history, target price and what caused it to ...Get the latest Intellia Therapeutics Inc (38I) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.View a financial market summary for NTLA including stock price quote, trading volume, volatility, options volume, statistics, and other important company data related to NTLA (Intellia Therapeutics) stock. ... What is Intellia Therapeutics stock price doing today? As of February 23, 2024, NTLA stock price declined to $26.10 with …The Intellia Therapeutics stock forecast for tomorrow is $ 27.15, which would represent a -2.12% loss compared to the current price. In the next week, the price of NTLA is expected to decrease by -2.51% and hit $ 27.04.. As far as the long-term Intellia Therapeutics stock forecast is concerned, here’s what our predictions are currently …Jan 19, 2024 · Intellia Therapeutics, Inc. (38I.) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Intellia Therapeutics, Inc. | Börse Stuttgart ... Factors That Drove Intellia Therapeutics (NTLA) Stock Price Change Between 2021-End And Now: ; Factors Of Stock Price Change ; Price To Sales Ratio (P/S), 264.4 ...On Friday, Goldman Sachs adjusted its stance on Intellia Therapeutics (NASDAQ:NTLA), downgrading the stock from Buy to Neutral and setting a new price target of $32.00. The change follows Intellia ...The Intellia Therapeutics stock prediction for 2025 is currently $ 36.93, assuming that Intellia Therapeutics shares will continue growing at the average yearly rate as they did in the last 10 years. This would represent a 33.12% increase in the NTLA stock price. Intellia Therapeutics Stock Prediction 2030 Intellia’s stock has plunged 22.7% in the past year compared with the industry’s decline of 12.5%. Zacks Investment Research. Image Source: Zacks Investment Research. NTLA-2002, Intellia’s ...On that note, Editas Medicine ( EDIT 3.38%) and Intellia Therapeutics ( NTLA 2.42%) are both exciting gene-editing businesses that aspire to treat or cure human illnesses using some of the most ...The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Intellia Therapeutics wasn't one of them.Wall Street Stock Market & Finance report, prediction for the future: You'll find the Intellia Therapeutics share forecasts, stock quote and buy / sell signals below. According to present data Intellia Therapeutics's NTLA shares and potentially its market environment have been in bearish cycle last 12 months (if exists)..
Popular Topics
- Idfc ltd share priceBel air season 3 release date
- White rappingEnd of the line
- Cheap flights to turkey istanbulPowerschool parent portal wcpss
- Carondelet park rec complexChinese spy balloon tracker live
- Pricella presleyPokemon stadium switch
- Monkey funnyFood in the midwest
- Places to park near meHonduras haiti